Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Horizon Therapeutics Publ...

    NASDAQ: HZNP · Real-Time Price · USD
    116.30
    0.00 (0.00%)
    At close: Jan 16, 2025, 10:00 PM

    Horizon Therapeutics Public Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Net Income
    		 521.48M 534.49M
    Depreciation & Amortization
    		 390.39M 353.75M
    Stock-Based Compensation
    		 182.1M 219.09M
    Other Working Capital
    		 -146.88M -85.61M
    Other Non-Cash Items
    		 126.03M 90.7M
    Deferred Income Tax
    		 49.81M -101.02M
    Change in Working Capital
    		 -11.98M -61.74M
    Operating Cash Flow
    		 1.26B 1.04B
    Capital Expenditures
    		 -126.28M -126.17M
    Cash Acquisitions
    		 -3.12M -2.85B
    Purchase of Investments
    		 -9.24M -24.67M
    Sales Maturities Of Investments
    		 4.63M -49.57M
    Other Investing Acitivies
    		 n/a 51.57M
    Investing Cash Flow
    		 -134M -2.99B
    Debt Repayment
    		 n/a n/a
    Common Stock Repurchased
    		 -250.08M n/a
    Dividend Paid
    		 n/a n/a
    Other Financial Acitivies
    		 -347.96M 1.47B
    Financial Cash Flow
    		 -347.96M 1.47B
    Net Cash Flow
    		 773.43M -499.32M
    Free Cash Flow
    		 1.13B 909.1M

    Add to Watchlist